Cash and Cash Equivalents |
| Note 7 | Cash and Cash Equivalents |
| |
2022 | | |
2021 | |
| |
A$ | | |
A$ | |
Cash at bank1 | |
| 6,011,368 | | |
| 2,172,499 | |
1 | Cash at bank earns interest at floating rates based on daily
deposit rates. |
Reconciliation to the Statement of Cash Flows: For the purposes of the Statement of Cash Flows,
cash and cash equivalents comprise cash on hand and at bank and investments in money market instruments, net of any outstanding bank overdrafts. Cash and cash equivalents as shown in the Statement
of Cash Flows is reconciled to the related items in the Statement of Financial Position as follows:
| |
2022 | | |
2021 | |
| |
A$ | | |
A$ | |
Cash and cash equivalents | |
| 6,011,368 | | |
| 2,172,499 | |
Non-cash financing and investing
activities: There were no non-cash financing or investing
activities during the years ended 30 June 2022 and 30 June 2021. Cash balances not available for
use: There are no amounts included in cash and cash equivalents not available
for use as at 30 June 2022 (30 June 2021: Nil). Reconciliation of loss after tax to net
cash outflow from operating activities:
| |
Restated
2022 | | |
2021 | |
| |
A$ | | |
A$ | |
Loss from ordinary activities after income tax | |
| (20,076,843 | ) | |
| (14,060,992 | ) |
Adjustments for non-cash items: | |
| | | |
| | |
Depreciation and amortisation | |
| 363,695 | | |
| 349,387 | |
Impairment expense | |
| 4,175,993 | | |
| 2,812,687 | |
Share-based payments expense | |
| 7,452,583 | | |
| 7,295,966 | |
Finance costs | |
| - | | |
| 250,668 | |
Fair value loss on convertible notes | |
| 781,492 | | |
| - | |
Unrealised foreign currency losses | |
| 142,836 | | |
| (233,179 | ) |
Accrued interest | |
| (155,157 | ) | |
| (34,881 | ) |
| |
| | | |
| | |
Movement in assets and liabilities: | |
| | | |
| | |
Decrease/(increase) in prepaid expenses | |
| 9,542 | | |
| (610,787 | ) |
Decrease in inventories | |
| - | | |
| 4,734 | |
Decrease/(increase) in trade and other receivables | |
| 192,124 | | |
| 50,822 | |
(Increase) in investments | |
| (2,565,082 | ) | |
| - | |
(Decrease)/increase in employee liabilities/provisions | |
| 7,106 | | |
| 126,528 | |
(Decrease)/increase in deferred income | |
| (132,800 | ) | |
| 132,800 | |
(Decrease)/increase in trade and other payables | |
| (54,288 | ) | |
| (185,839 | ) |
Net cash flow used in operating activities | |
| (9,858,799 | ) | |
| (4,102,086 | ) |
|